The Pharmacy Times® Diabetes Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of chronic diseases that result in high blood glucose.
April 23rd 2024
Conversations and counseling points should be tailored to patients’ individual needs and treatment goals
Continuing the Conversation: Advancements in Integrated Continuous Glucose Monitoring Devices and Best Practices to Customize Care (Technician Credit)
2 Credits / Endocrinology Diabetes & Metabolism
View More
Continuing the Conversation: Advancements in Integrated Continuous Glucose Monitoring Devices and Best Practices to Customize Care
2 Credits / Endocrinology Diabetes & Metabolism
View More
The Emerging Treatment Landscape for Hemophilia A and the Valuable Role of the Specialty Pharmacist
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access
1.5 Credits / Endocrinology, Diabetes & Metabolism, Oncology
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
Delving Into the Latest Integrated Continuous Glucose Monitoring Devices: An Interdisciplinary Approach With Case Discussions to Enhance Diabetes Care (Pharmacy Technician Cre...
1.5 Credits / Endocrinology Diabetes & Metabolism
View More
The Role of Integrated Continuous Glucose Monitoring in Improving Clinical Outcomes in Diabetes
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Diabetes Management With Integrated Continuous Glucose Monitoring Devices: Pharmacist Best Practices for Individualizing Treatment
0.75 Credit / Endocrinology Diabetes & Metabolism
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Continuous Glucose Monitoring in Diabetes Care: Examining the Value and Addressing Barriers to Access
3.5 Credits / Endocrinology, Diabetes & Metabolism
View More
Introduction to Chronic Kidney Disease in People Living With Type 2 Diabetes: Combating Disease Progression and Complications
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Examining Current and Emerging Therapies to Slow Progression of Chronic Kidney Disease
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Tailoring Recommendations for People Living With Type 2 Diabetes and Chronic Kidney Disease: The Role of the Pharmacist
1.0 Credit / Endocrinology, Diabetes, and Metabolism, Nephrology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
NSAIDs Linked to Thousands of Heart Failure Hospitalizations Among Patients With Type 2 Diabetes
September 7th 2022A recent study suggests that infrequently taking non-steroidal anti-inflammatory drugs, especially ibuprofen, with type 2 diabetes can increase the risk of first-time heart failure and hospitalization.
Read More
Expert: Whole Government, Whole Country Approach Needed to End Diet-related Diseases
August 29th 2022Catherine Oakar, special assistant to the President for Public Health and Disparities in the Domestic Policy Council at The White House, discusses plans to address diet-related diseases in a conference held at The White House in September 2022.
Read More
Clinical Overview: Certain Antihypertensive Drugs Can Lower Risk for New Onset Type 2 Diabetes
August 10th 2022Meta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Read More
Case Study: Insulin Sensitizers as Enhancers in Diabetes Management
July 14th 2022The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Read More